» Articles » PMID: 24070124

Microfluidic Chip-based Technologies: Emerging Platforms for Cancer Diagnosis

Overview
Journal BMC Biotechnol
Publisher Biomed Central
Specialty Biotechnology
Date 2013 Sep 28
PMID 24070124
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The development of early and personalized diagnostic protocols is considered the most promising avenue to decrease mortality from cancer and improve outcome. The emerging microfluidic-based analyzing platforms hold high promises to fulfill high-throughput and high-precision screening with reduced equipment cost and low analysis time, as compared to traditional bulky counterparts in bench-top laboratories. This article overviewed the potential applications of microfluidic technologies for detection and monitoring of cancer through nucleic acid and protein biomarker analysis. The implications of the technologies in cancer cytology that can provide functional personalized diagnosis were highlighted. Finally, the future niches for using microfluidic-based systems in tumor screening were briefly discussed.

Citing Articles

Application of microfluidic technology based on surface-enhanced Raman scattering in cancer biomarker detection: A review.

Nie C, Shaw I, Chen C J Pharm Anal. 2024; 13(12):1429-1451.

PMID: 38223444 PMC: 10785256. DOI: 10.1016/j.jpha.2023.08.009.


Towards a New 3Rs Era in the construction of 3D cell culture models simulating tumor microenvironment.

Zhang L, Liao W, Chen S, Chen Y, Cheng P, Lu X Front Oncol. 2023; 13:1146477.

PMID: 37077835 PMC: 10106600. DOI: 10.3389/fonc.2023.1146477.


Advances in Microfluidics for the Implementation of Liquid Biopsy in Clinical Routine.

Teixeira A, Carneiro A, Piairo P, Xavier M, Ainla A, Lopes C Adv Exp Med Biol. 2022; 1379:553-590.

PMID: 35761007 DOI: 10.1007/978-3-031-04039-9_22.


Microfluidic Platforms to Unravel Mysteries of Alzheimer's Disease: How Far Have We Come?.

Prasanna P, Rathee S, Rahul V, Mandal D, Chandra Goud M, Yadav P Life (Basel). 2021; 11(10).

PMID: 34685393 PMC: 8537508. DOI: 10.3390/life11101022.


Scalable Signature-Based Molecular Diagnostics Through On-chip Biomarker Profiling Coupled with Machine Learning.

Molinski J, Tadimety A, Burklund A, Zhang J Ann Biomed Eng. 2020; 48(10):2377-2399.

PMID: 32816167 PMC: 7785517. DOI: 10.1007/s10439-020-02593-y.


References
1.
Wheeler A, Moon H, Bird C, Ogorzalek Loo R, Kim C, Loo J . Digital microfluidics with in-line sample purification for proteomics analyses with MALDI-MS. Anal Chem. 2005; 77(2):534-40. DOI: 10.1021/ac048754+. View

2.
Will B, Steidl U . Multi-parameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignancies. Best Pract Res Clin Haematol. 2010; 23(3):391-401. PMC: 3052971. DOI: 10.1016/j.beha.2010.06.006. View

3.
Bilkenroth U, Taubert H, Riemann D, Rebmann U, Heynemann H, Meye A . Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation. Int J Cancer. 2001; 92(4):577-82. DOI: 10.1002/ijc.1217. View

4.
Cho S, Kang D, Choo J, de Mello A, Chang S . Recent advances in microfluidic technologies for biochemistry and molecular biologys. BMB Rep. 2011; 44(11):705-12. DOI: 10.5483/BMBRep.2011.44.11.705. View

5.
Tothill I . Biosensors for cancer markers diagnosis. Semin Cell Dev Biol. 2009; 20(1):55-62. DOI: 10.1016/j.semcdb.2009.01.015. View